Copenhagen, Denmark

Helga David



Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Location History:

  • København, DK (2013)
  • Copenhagen, DK (2017)

Company Filing History:


Years Active: 2013-2017

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Helga David: A Pioneer in Bioengineering Innovations

Introduction

Helga David, an innovative inventor based in Copenhagen, Denmark, has made significant contributions to the field of bioengineering. With two patents to her name, she has been at the forefront of developing genetically engineered microorganisms designed for the production of valuable compounds, such as pinosylvin. Her work exemplifies the intersection of creativity and scientific advancement, positioning her as a notable figure in her industry.

Latest Patents

One of Helga David's latest patents focuses on "Metabolically Engineered Cells for the Production of Pinosylvin." This innovation describes a genetically engineered microorganism equipped with an operative metabolic pathway that produces cinnamoyl-CoA, which is essential for pinosylvin production through the action of stilbene synthase. Notably, the patent details the process of forming cinnamic acid from L-phenylalanine via a specific enzyme called L-phenylalanine ammonia lyase (PAL). This PAL enzyme is designed to accept phenylalanine as a substrate, converting it into cinnamic acid, with specific ratios to ensure optimal production.

Career Highlights

Throughout her career, Helga David has collaborated with prestigious companies such as Fluxome Sciences A/S and Evolva SA. Her roles at these organizations have allowed her to apply her innovative ideas to practical applications in biotechnology, particularly in creating sustainable solutions for producing vital compounds.

Collaborations

Working alongside accomplished individuals like Michael Katz and Hans Peter Schmidt, Helga has fostered an environment of innovation and collaboration. Together, they have explored various approaches to optimize genetically engineered organisms, contributing to advancements in metabolic engineering.

Conclusion

Helga David's dedication to innovation in bioengineering, evidenced by her impactful patents and collaborations, positions her as a significant figure in the quest for sustainable biotechnological solutions. As she continues to push the boundaries of her research, her work not only advances scientific knowledge but also paves the way for future innovations in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…